BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

Compugen deal

Compugen received $5 million in R&D funding from investment firm Baize Investments Ltd. to support Compugen's Pipeline Program, which consists of more than 30 mAbs and proteins in discovery and preclinical testing for cancer, autoimmune...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >